Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Preferred Stock Liabilities: 2023

Historic Preferred Stock Liabilities for Upstream Bio (UPB) over the last 1 years, with Dec 2023 value amounting to $230.9 million.

  • Upstream Bio's Preferred Stock Liabilities rose 64.93% to $380.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $380.9 million, marking a year-over-year increase of 64.93%. This contributed to the annual value of $230.9 million for FY2023, which is N/A change from last year.
  • As of FY2023, Upstream Bio's Preferred Stock Liabilities stood at $230.9 million.
  • Upstream Bio's 5-year Preferred Stock Liabilities high stood at $230.9 million for FY2023, and its period low was $230.9 million during FY2023.
  • Its 1-year average for Preferred Stock Liabilities is $230.9 million, with a median of $230.9 million in 2023.